Aeglea

Developer of drugs for rare metabolic disorders

placeAustin, Texas, United States calendar_todayFounded 2013 groups81 employees language aeglea.com

Registered entities

Investor mix

12 investors on record; lead investors include Austin Technology Incubator, Hunter Trust, Lilly Ventures, Novartis Venture Fund.

Investor typeCountShare
Venture capital542%
Private equity18%
Accelerator & incubator18%
Bank & private debt18%
Other / undisclosed433%
Coming soon